Myda Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Myda Advisors LLC

  • $407 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019
SELL
$151.91 - $192.21 $455,730 - $576,630
-3,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $503,189 - $578,220
3,000 New
3,000 $578,000
Q1 2018

May 10, 2018
SELL
$151.6 - $177.13 $1.52 Million - $1.77 Million
-10,000 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$137.28 - $155.55 $1.37 Million - $1.56 Million
10,000
10,000 $1.5 Million

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Myda Advisors LLC Portfolio

Follow Myda Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Myda Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email